[
  {
    "ts": null,
    "headline": "Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors",
    "summary": "Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=e1bf2e5fab50672d43617755af2a30eef5dcdee768684beafcadca817e8a090d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760115120,
      "headline": "Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors",
      "id": 137114974,
      "image": "",
      "related": "EW",
      "source": "MarketWatch",
      "summary": "Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=e1bf2e5fab50672d43617755af2a30eef5dcdee768684beafcadca817e8a090d"
    }
  },
  {
    "ts": null,
    "headline": "Abbott to Report Q3 Earnings: Medical Devices Arm in Focus",
    "summary": "ABT's Q3 results may show strength in Medical Devices and Nutrition, offsetting softness in Diagnostics.",
    "url": "https://finnhub.io/api/news?id=8407a20195b135f215de7573f5bd6a8acefa97d287386f4ecaf547d3889da9b5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760100240,
      "headline": "Abbott to Report Q3 Earnings: Medical Devices Arm in Focus",
      "id": 137041615,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "ABT's Q3 results may show strength in Medical Devices and Nutrition, offsetting softness in Diagnostics.",
      "url": "https://finnhub.io/api/news?id=8407a20195b135f215de7573f5bd6a8acefa97d287386f4ecaf547d3889da9b5"
    }
  },
  {
    "ts": null,
    "headline": "Edwards Lifesciences (EW): Assessing Valuation Following Recent Share Price Decline",
    "summary": "Edwards Lifesciences (EW) has seen its stock trend lower over the past month, down about 6%. Investors are keeping an eye on recent performance and fundamentals as they review the company’s latest results and outlook. See our latest analysis for Edwards Lifesciences. Despite some recent weakness in the share price, with a 1-month share price return of -5.8%, Edwards Lifesciences still boasts a 1-year total shareholder return of 10.2%. While momentum has faded since the start of the year, its...",
    "url": "https://finnhub.io/api/news?id=e29f7c64c265c34789eeca605b5a4d98f72403679a62d75d26befbc31560748a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760072934,
      "headline": "Edwards Lifesciences (EW): Assessing Valuation Following Recent Share Price Decline",
      "id": 137042097,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Edwards Lifesciences (EW) has seen its stock trend lower over the past month, down about 6%. Investors are keeping an eye on recent performance and fundamentals as they review the company’s latest results and outlook. See our latest analysis for Edwards Lifesciences. Despite some recent weakness in the share price, with a 1-month share price return of -5.8%, Edwards Lifesciences still boasts a 1-year total shareholder return of 10.2%. While momentum has faded since the start of the year, its...",
      "url": "https://finnhub.io/api/news?id=e29f7c64c265c34789eeca605b5a4d98f72403679a62d75d26befbc31560748a"
    }
  }
]